GCA

Bertha Oketch and her team are piloting the integration of artificial intelligence (AI) with the neoGuard™ vitals monitoring device, developed by Neopenda, in two Kenyan hospitals — Moi Teaching and Referral Hospital and Bungoma County Referral Hospital. The device, which continuously monitors newborns’ vital signs (temperature, pulse rate, respiratory rate, and oxygen saturation), will be enhanced with AI capabilities to support predictive analytics for respiratory distress syndrome (RDS) equipment needs.

An expert in HIV and TB prevention, control, and treatment, Daniel has spent the past eighteen years leading public health programs and implementation studies in resource-limited settings in Kenya. He has played a pivotal role in developing and testing new service delivery models to improve access to HIV treatment and has contributed to product redesign efforts for HIV prevention tools, including digital solutions. His experience also includes serving as a frontline healthcare provider in these settings.